Compare Cigna Corp (CI) vs SOLAI Limited (SLAI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cigna Corp vs SOLAI Limited — how do they compare? Cigna Corp trades at $272.72 (market cap $73.56B), while SOLAI Limited trades at $3.72 (market cap $16.69M). The key difference: Cigna Corp is far larger — about 4407.4× SOLAI Limited's market cap, and Cigna Corp pays a 2.24% dividend while SOLAI Limited pays none. Which is the better fit depends on your goals.
| CI | SLAI | |
|---|---|---|
Market Cap | $73.56B | $16.69M |
Sector | Health | Technology |
52-Week High | $311.00 | $26.74 |
52-Week Low | $244.41 | $2.74 |
Enterprise Value | $98.27B | $16.33M |
Dividend Yield | 2.24% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cigna (CI) trades at $282.49, up 2.63% with strong earnings beats in recent quarters. The stock shows bearish technical signals but benefits from low valuation ratios like a P/E of 11.68 and P/S of 0.27. Recent Q2 2026 results exceeded expectations, with EPS of $7.78 beating estimates, and the company raised its full-year guidance to at least $30.45 adjusted EPS, reflecting robust growth in health services and insurance segments.
The outlook is positive due to consistent earnings outperformance and raised guidance, though technical weakness and competitive pressures pose risks. Analyst consensus is strongly bullish with a $338.90 price target, indicating ~20% upside potential from current levels, supported by dividend payments and institutional accumulation.
SLAI trades at $3.72 with no recent price movement. The company faces severe financial distress with negative gross and net income margins, substantial losses, and a recent delisting notice from the NYSE. Technical indicators show a bullish signal despite fundamental weakness, while the sole analyst coverage maintains a hold rating. Recent corporate actions include a reverse stock split and acquisition activity.
The outlook remains highly speculative with significant execution and regulatory risks. Investment opportunity exists only for risk-tolerant investors betting on the company's AI infrastructure pivot, but current financials and delisting proceedings present substantial downside potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cigna Corp
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.
Read more on CI →About SOLAI Limited
SOLAI focuses on providing innovative AI-driven software solutions. The company leverages artificial intelligence to enhance digital experiences and optimize business processes for various industries.
Read more on SLAI →
